SNOA Sonoma Pharmaceuticals Earnings per share growth this year

SNOA (sonomapharma.com) - company brandmark

Sonoma Pharmaceuticals develops tissue regeneration products using affordable formulas for mass production. Manufacturing processes are fully outsourced to external contractors, leaving the company dependent on third-party plants. The current stage of development is characterized by the promotion of the Microcyn line through veterinary centers and pharmacies. The annual EPS percentage change demonstrates profitability dynamics, where the value 0.00 represents the current figure.

SNOA sonomapharma.com Earnings per share growth in current year (07/04/2022 - 11/18/2026)

Analytical breakdowns and data insights for company sonomapharma.com (SNOA)

- current quotes and average value forecast:
Basic company analysis:SNOA, Sonoma Pharmaceuticals
Brand item of Sonoma Pharmaceuticals

Fundamental asset screening requires an accurate assessment of shareholder value dynamics. By analyzing the percentage deviation of EPS from the previous year's level, an investor determines the rate of change in net profit per share, which reveals the business's resilience to market shocks. For Sonoma Pharmaceuticals (SNOA), this indicator reflects the effectiveness of diversification within the dermatology and hygiene segment when supplying global pharmacy chains.